Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Jun 27.

Published in final edited form as: Lancet Microbe. 2022 Jan 24;3(3):e203–e214. doi: 10.1016/S2666-5247(21)00239-1

Figure 4. — Time to viral rebound during analytical treatment interruption. (A) Individual plasma HIV-1 RNA levels after interruption of antiretroviral therapy; the dotted line represents the limit of quantification (20 copies per mL). (B) Proportion of individuals with plasma HIV-1 RNA of less than 200 copies per mL after interruption of antiretroviral therapy. ART=antiretroviral therapy, ATI=analytical treatment interruption, RMD=romidepsin.

Figure 4. — Time to viral rebound during analytical treatment interruption. (A) Individual plasma HIV-1 RNA levels after interruption of antiretroviral therapy; the dotted line represents the limit of quantification (20 copies per mL). (B) Proportion of individuals with plasma HIV-1 RNA of less than 200 copies per mL after interruption of antiretroviral therapy. ART=antiretroviral therapy, ATI=analytical treatment interruption, RMD=romidepsin.